(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 10.92%
5.67% $ 0.820
Live Chart Being Loaded With Signals
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system...
Stats | |
---|---|
Volumen de hoy | 116 465 |
Volumen promedio | 417 803 |
Capitalización de mercado | 3.76M |
EPS | $0 ( 2024-04-03 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.160 |
ATR14 | $0.00400 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Kontulis Caitlin | Sell | 335 | Common stock, $0.0001 par value |
2024-02-26 | Bitterman Robert J | Buy | 2 500 | Common stock, $0.0001 par value |
2024-02-20 | Bitterman Robert J | Sell | 1 804 | Common stock, $0.0001 par value |
2024-02-15 | Kontulis Caitlin | Sell | 658 | Common stock, $0.0001 par value |
2024-02-17 | Kontulis Caitlin | Sell | 523 | Common stock, $0.0001 par value |
INSIDER POWER |
---|
76.83 |
Last 97 transactions |
Buy: 3 139 429 | Sell: 140 691 |
Volumen Correlación
Phio Pharmaceuticals Corp Correlación
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Phio Pharmaceuticals Corp Correlación - Moneda/Commodity
Phio Pharmaceuticals Corp Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-184 000 (0.00 %) |
EPS: | $-5.20 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-184 000 (0.00 %) |
EPS: | $-5.20 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-193 000 (0.00 %) |
EPS: | $-9.95 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-12.43 |
Financial Reports:
No articles found.
Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico